Federica Beretta Francesca Dassie Matteo Parolin Federico Boscari Mattia Barbot Luca Busetto Roberto Mioni Eugenio De Carlo Carla Scaroni Francesco Fallo Roberto Vettor Pietro Maffei
10.3389/fendo.2020.00554
Front Endocrinol (Lausanne)
2020 Sep 11;11:554.
cushing's disease sars-cov-2 hypercortisolism pituitary rare diseases
CC BY
https://pubmed.ncbi.nlm.nih.gov/33071957/
Betacoronavirus / drug effects Coronavirus Infections / drug therapy Cushing Syndrome / drug therapy Hydrocortisone / therapeutic use Metyrapone / therapeutic use Pneumonia, Viral / drug therapy
Betacoronavirus / drug effects Coronavirus Infections / drug therapy Cushing Syndrome / drug therapy Hydrocortisone / therapeutic use Metyrapone / therapeutic use Pneumonia, Viral / drug therapy Case Reports Aged Anti-Inflammatory Agents / therapeutic use Antimetabolites / therapeutic use Betacoronavirus / isolation & purification COVID-19 Coronavirus Infections / complications Coronavirus Infections / virology Cushing Syndrome / complications Cushing Syndrome / virology Disease Management Humans Male Pandemics Pneumonia, Viral / complications Pneumonia, Viral / virology SARS-CoV-2 Anti-Inflammatory Agents Antimetabolites Hydrocortisone Metyrapone
PMC7533597
33071957
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report
2020